A multicentre double-blind comparison of auranofin, intramuscular gold thiomalate and placebo in patients with psoriatic arthritis

British Journal of Rheumatology
J PalitG Nuki

Abstract

The efficacy and safety of the oral gold compound auranofin and intramuscular gold thiomalate have been compared in a placebo-controlled, double-blind, four-centre trial in 82 patients with psoriatic arthritis requiring remittive drug therapy. There were statistically significant falls in Ritchie articular index, visual analogue pain score and ESR at 12 and 24 weeks following i.m. gold but no significant changes in the auranofin group. Intramuscular gold was safe and more effective than auranofin as a second-line, suppressive antirheumatic agent for patients with psoriatic arthritis when followed for 6 months.

Citations

Jul 10, 2002·Joint, Bone, Spine : Revue Du Rhumatisme·Philippe Goupille
Jul 10, 2002·Joint, Bone, Spine : Revue Du Rhumatisme·Laurent MarguerieBernard Delcambre
Feb 15, 2005·Annals of the Rheumatic Diseases·P Nash, D O Clegg
Nov 17, 2010·Indian Journal of Dermatology, Venereology and Leprology·Aman Sharma, Sunil Dogra
Jul 18, 2001·Springer Seminars in Immunopathology·A M van TubergenS van der Linden
Aug 21, 2009·Current Rheumatology Reports·Peter Nash
Nov 4, 2000·Expert Opinion on Investigational Drugs·D D Gladman, J Brockbank
Apr 30, 2003·Expert Opinion on Biological Therapy·Allen P Anandarajah, Christopher T Ritchlin
Mar 5, 2004·Expert Opinion on Investigational Drugs·Roopa Prasad, Dafna Gladman
Apr 7, 2007·Rheumatic Diseases Clinics of North America·Philip Mease
Feb 19, 2009·Dermatologic Therapy·Dafna D Gladman
Apr 14, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·P LawsR B Warren
Aug 1, 1997·Seminars in Arthritis and Rheumatism·I OlivieriI Portioli
Sep 1, 1999·Rheumatic Diseases Clinics of North America·D VassilopoulosR M Strauss
Sep 4, 2003·Rheumatic Diseases Clinics of North America·Philip J Mease
Sep 29, 2004·Dermatologic Clinics·Eric M Ruderman, Siddharth Tambar
Sep 24, 2004·Dermatologic Therapy·Dafna D Gladman
Mar 30, 2007·Arthritis and Rheumatism·Anthony M Turkiewicz, Larry W Moreland
Jan 5, 2002·American Journal of Clinical Dermatology·C G Jackson
Jan 24, 2006·American Journal of Therapeutics·Augustine M ManadanJoel A Block
Jul 25, 2000·The Cochrane Database of Systematic Reviews·G JonesP Brooks
Mar 29, 2005·Hospital Medicine·William J Taylor
Nov 8, 2002·Drugs·John Brockbank, Dafna Gladman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.